Related Articles by Review for PMID: 19691092

Year	Number of Results
1992	1
1999	1
2000	2
2003	2
2004	3
2005	2
2006	7
2007	6
2008	12
2009	25
2015	1
2016	1
2024	0

1

A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer: quality of life outcomes.

Robinson JW, Donnelly BJ, Siever JE, Saliken JC, Ernst SD, Rewcastle JC, Trpkov K, Lau H, Scott C, Thomas B. Robinson JW, et al. Cancer. 2009 Oct 15;115(20):4695-704. doi: 10.1002/cncr.24523. Cancer. 2009. PMID: 19691092 Free article. Clinical Trial.

2

External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life.

Di Lorenzo G, Autorino R, Ciardiello F, Raben D, Bianco C, Troiani T, Pizza C, De Laurentiis M, Pensabene M, D'Armiento M, Bianco AR, De Placido S. Di Lorenzo G, et al. Oncol Rep. 2003 Mar-Apr;10(2):399-404. Oncol Rep. 2003. PMID: 12579279 Review.

3

Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?

Roach M 3rd. Roach M 3rd. Strahlenther Onkol. 2007 Dec;183 Spec No 2:26-8. doi: 10.1007/s00066-007-2011-8. Strahlenther Onkol. 2007. PMID: 18167004 Review.

4

Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC.

Scalliet PG, Remouchamps V, Curran D, Ledent G, Wambersie A, Richard F, van Cangh P. Scalliet PG, et al. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1549-61. doi: 10.1016/j.ijrobp.2003.09.001. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050336 Review.

5

Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?

Parker WR, Montgomery JS, Wood DP Jr. Parker WR, et al. Curr Opin Urol. 2009 May;19(3):303-8. doi: 10.1097/MOU.0b013e328329eb00. Curr Opin Urol. 2009. PMID: 19300266 Review.

6

Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?

Klein EA, Ciezki J, Kupelian PA, Mahadevan A. Klein EA, et al. Urol Oncol. 2009 Jan-Feb;27(1):67-71. doi: 10.1016/j.urolonc.2008.04.001. Urol Oncol. 2009. PMID: 19111801 Review.

7

Sexual function after external-beam radiotherapy for prostate cancer: what do we know?

Incrocci L. Incrocci L. Crit Rev Oncol Hematol. 2006 Feb;57(2):165-73. doi: 10.1016/j.critrevonc.2005.06.006. Epub 2005 Dec 1. Crit Rev Oncol Hematol. 2006. PMID: 16325413 Free article. Review.

8

Low and intermediate risk prostate cancer-- role of hormonal therapy with external beam radiation therapy.

Martin J, Bristow R, Warde P. Martin J, et al. Can J Urol. 2006 Apr;13 Suppl 2:63-7. Can J Urol. 2006. PMID: 16672132 Review.

9

[Treatment of clinically localized prostate cancer. Part III--external beam radiotherapy].

Gisterek I, Szelachowska J, Kornafel J. Gisterek I, et al. Pol Merkur Lekarski. 2006 Dec;21(126):602-6. Pol Merkur Lekarski. 2006. PMID: 17405307 Review. Polish.

10

A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.

Wolff RF, Ryder S, Bossi A, Briganti A, Crook J, Henry A, Karnes J, Potters L, de Reijke T, Stone N, Burckhardt M, Duffy S, Worthy G, Kleijnen J. Wolff RF, et al. Eur J Cancer. 2015 Nov;51(16):2345-67. doi: 10.1016/j.ejca.2015.07.019. Epub 2015 Aug 5. Eur J Cancer. 2015. PMID: 26254809 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year